Lana Medical (9587) Fundamentals 2026 — P/E 44.2x, Revenue Analysis | SniperIQ
Lana Medical (9587) is a SA-listed Healthcare company in Medical - Care Facilities with a market capitalization of SAR 135M, trading at SAR 2.50 on the SAU. This SniperIQ fundamentals page covers Lana Medical's valuation (P/E 44.2x, P/B 2.1x), profitability (net margin 2.7%), revenue (SAR 92M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Lana Medical's market cap?
Lana Medical (9587) has a market capitalization of approximately SAR 135M, trading at SAR 2.50 on the SAU. Market cap moves with the live share price.
What is Lana Medical's P/E ratio?
Lana Medical's trailing twelve-month P/E ratio is 44.2x, with a price-to-book (P/B) of 2.1x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Lana Medical?
Lana Medical runs a net profit margin of 2.7%, a gross margin of 25.4%, and an operating margin of 8.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Lana Medical generate?
Lana Medical reported revenue of SAR 92M for fiscal year 2025, with net income of SAR 3M and earnings per share (EPS) of 0.05. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Lana Medical pay a dividend?
Lana Medical offers a trailing dividend yield of about 1.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Lana Medical financially healthy?
Lana Medical carries a debt-to-equity ratio of 0.45x and a current ratio of 1.58x, with a market beta of -0.14. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Lana Medical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Lana Medical (9587) the key facts are: market cap SAR 135M, P/E 44.2x, revenue SAR 92M, 52-week range 2.07-3.778. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Lana Medical's full fundamentals live
Get Lana Medical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.